COLGATE PALMOLIVE CO 8-K

What Happened

• On May 1, 2026, Colgate-Palmolive Company issued a press release (attached as Exhibit 99) announcing its earnings for the quarter ended March 31, 2026.
• The Company’s Board approved an expansion of its Strategic Growth and Productivity Program on April 30, 2026 (originally approved July 31, 2025). The program’s estimated cumulative pre-tax charges were increased to $350 million–$550 million (previously $200 million–$300 million).

Key Details

• Total estimated cumulative pre-tax charges: $350M to $550M (up from $200M–$300M).
• Charge composition: ~70%–80% employee-related costs (severance and termination benefits); ~20%–30% asset-related and other charges (accelerated depreciation, write-offs, contract termination, exit costs).
• Cash impact and timing: ~80%–90% of charges expected to be cash expenditures; substantially all charges to be incurred by December 31, 2028.
• Geographic allocation of charges (estimated): North America 5%–10%; Latin America 15%–20%; EMEA 25%–30%; Asia Pacific 10%–15%; Hill’s Pet Nutrition 10%–15%; Corporate 20%–25%.

Why It Matters

• The expanded program increases near-term restructuring costs that will weigh on reported earnings in the affected periods, but the Company frames the actions as investments to improve efficiency and support its 2030 strategy.
• Most of the charges are forecasted to be cash payments and to be realized by the end of 2028, so investors can expect the impact concentrated over the next few years rather than ongoing long-term expense.
• The filing contains forward-looking estimates and cautions that actual results may differ; investors should review Colgate-Palmolive’s SEC filings (including the 2025 Form 10-K risk factors) for additional context.